1 completed, 1 withdrawn. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Withdrawn 1 |
Follow Refractory Meningioma: new trials by email Literature Review of Refractory Meningioma trials Research Report on Refractory Meningioma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study of ONC201 for Refractory Meningioma ONC201 - Meningioma, Refractory Meningioma | Phase 2 | Withdrawn | University of Nebraska | 2026-12-01 | 2026-01-26 | |
| Semi-automated Segmentation Methods of SSTR PET for Dosimetry Prediction To evaluate the SUVmean (Standard Uptake Value) as a predictive factor of the tumor absorbed dose compared to the SUVmax - Refractory Meningioma | Completed | Central Hospital, Nancy, France | 20 | 2022-10-01 | 2023-11-30 |
Meningioma (2)
Central Nervous System Neoplasms (2) · Meningeal Neoplasms (2) · Neoplasms (2) · Neoplasms by Histologic Type (2) · Neoplasms by Site (2) · Neoplasms, Nerve Tissue (2) · Neoplasms, Vascular Tissue (2) · Nervous System Diseases (2) · Nervous System Neoplasms (2)
TIC10 compound (1)
Central Hospital, Nancy, France (1) · University of Nebraska (1)
France (1)